Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6690696.pdf
Reference19 articles.
1. Gengo, FM, Schentag, JJ & Jusko, WJ (1984). Pharmacokinetics of capacity-limited distribution of methicillin in rabbits. J Pharm Sci 73: 867–873.
2. Gianni, L, Kearns, CM, Giani, A, Capri, G, Vigano, L, Lacatelli, A, Bonadonna, G & Egorin, MJ (1995). Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. J Clin Oncol 13: 180–190.
3. Huizing, MT, Keung, AC, Rosing, H, van der Kuij, V, ten Bokkel Huinink, WW, Mandjes, IM, Dubbelman, AC, Pinedo, HM & Beijnen, JH (1993). Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J Clin Oncol 11: 2127–2135.
4. Huizing, MT, Sewberath Misser, VH, Pieters, RC, ten Bokkel Huinink, WW, Veenhof, CH, Vermorken, JB, Pinedo, HM & Beijnen, JH (1995a). Taxanes: a new class of antitumor agents. Cancer Invest 13: 381–404.
5. Huizing, MT, Sparreboom, A, Rosing, H, Van Tellingen, O, Pinedo, HM & Beijnen, JH (1995b). Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 674: 261–268.
Cited by 150 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice;Pharmaceuticals;2023-12-29
2. Effectiveness of nab-paclitaxel versus traditional paclitaxels in the treatment of ovarian cancer;Tropical Journal of Pharmaceutical Research;2023-06-06
3. Organoids technology for advancing the clinical translation of cancer nanomedicine;WIREs Nanomedicine and Nanobiotechnology;2023-04-23
4. CELL INCORPORATION STUDY OF [99mTc]Tc-NAB-PACLITAXEL ON HUMAN COLORECTAL ADENOCARCINOMA CELL LINE;Ankara Universitesi Eczacilik Fakultesi Dergisi;2022-11-21
5. Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges;Biomolecules;2022-06-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3